Yalmo
AI System for Children with Autism Spectrum Disorder
Company Overview
Snapshot
Founded in April 2021 by Roman Karasik, Yalmo operates with 1–10 employees. The company secured a Pre-Seed funding round in September 2021 from the Israel Innovation Authority.
Business overview
Yalmo is a Health Tech & Life Sciences company that develops a personalized behavior-management AI platform for children with Autism Spectrum Disorder (ASD). The system monitors children's activities and provides solutions based on advanced data analysis to improve daily routines and prevent outbursts. Yalmo's technology aims to help families and caregivers understand challenging behaviors, adjust daily routines, and create a more secure environment, operating within the Digital Healthcare sector with a focus on Patient Remote Monitoring.
Strategic signal
Yalmo ceased operations in December 2024, indicating a significant strategic shift and the conclusion of its efforts in developing AI-powered solutions for children with Autism Spectrum Disorder. This event signals to investors and innovation teams the inherent risks and challenges within the specialized health tech market, particularly for early-stage ventures targeting niche patient populations.
Log in to access full profile ›Company Intelligence Q&A
- What is Yalmo's primary focus?
- Yalmo focuses on developing an AI system for children with Autism Spectrum Disorder to improve their quality of life and support their families.
- When was Yalmo founded?
- Yalmo was founded in April 2021.
- Who is a key founder of Yalmo?
- Roman Karasik is a co-founder and CEO of Yalmo.
- What was a significant funding event for Yalmo?
- In September 2021, Yalmo secured a Pre-Seed funding round from the Israel Innovation Authority.
- What is the current operational status of Yalmo?
- Yalmo ceased to operate in December 2024.